0719.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 04:08):

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products...

Stats
Today's Volume	590 000
Average Volume	1.16M
Market Cap	9.20B
EPS	HKD0.180 ( 2023-09-30 )
Last Dividend	HKD0.219 ( 2023-07-07 )
Next Dividend	HKD0 ( N/A )
P/E	6.73
ATR14	HKD0.00800 (0.15%)

Volume Correlation

Long: -0.11 (neutral)

Short: 0.00 (neutral)

Signal:(56.212) Neutral

Shandong Xinhua Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shandong Xinhua Correlation - Currency/Commodity

-0.47
( neutral )

-0.23
( neutral )

0.00
( neutral )

0.76
( moderate )

0.48
( neutral )

-0.56
( weak negative )

Shandong Xinhua Financials

Annual	2023
Revenue:	HKD8.10B
Gross Profit:	HKD2.39B (29.52 %)
EPS:	HKD0.740

Q4	2023
Revenue:	HKD1.60B
Gross Profit:	HKD501.58M (31.28 %)
EPS:	HKD0

Q3	2023
Revenue:	HKD1.83B
Gross Profit:	HKD498.90M (27.33 %)
EPS:	HKD0.180

Q2	2023
Revenue:	HKD2.03B
Gross Profit:	HKD562.88M (27.69 %)
EPS:	HKD0.180

Financial Reports:

No articles found.

Shandong Xinhua Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.176 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.219 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Shandong Xinhua Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.37 - Stable (7.40%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0308	2000-05-10
Last Dividend	HKD0.219	2023-07-07
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	HKD1.419	--
Avg. Dividend % Per Year	0.00%	--
Score	3.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.37
Div. Directional Score	8.64	--

Next Divdend (Est)
(2024-07-29)

HKD0.240 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.32

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3320.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
1543.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%
0590.HK	Ex Dividend Knight	2023-08-22	Semi-Annually	0.00%
8635.HK	No Dividend Player	2023-08-02	Annually	0.00%
2111.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
1117.HK	Ex Dividend Junior	2023-06-08	Sporadic	0.00%
0207.HK	Ex Dividend Junior	2023-06-12	Sporadic	0.00%
3808.HK	Ex Dividend Junior	2023-07-04	Annually	0.00%
1705.HK	Ex Dividend Knight	2023-09-25	Annually	0.00%
0732.HK	Ex Dividend Junior	2023-11-10	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0613	1.500	8.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0599	1.200	8.00	9.60	[0 - 0.3]
returnOnEquityTTM	0.112	1.500	9.86	10.00	[0.1 - 1]
payoutRatioTTM	0.354	-1.000	6.46	-6.46	[0 - 1]
currentRatioTTM	1.333	0.800	8.33	6.67	[1 - 3]
quickRatioTTM	0.750	0.800	-0.296	-0.237	[0.8 - 2.5]
cashRatioTTM	0.369	1.500	9.06	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	12.99	1.000	6.30	6.30	[3 - 30]
operatingCashFlowPerShareTTM	0.897	2.00	9.70	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.411	2.00	9.79	10.00	[0 - 20]
debtEquityRatioTTM	0.298	-1.500	8.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.295	1.000	8.41	8.41	[0.2 - 0.8]
operatingProfitMarginTTM	0.0660	1.000	-0.680	-0.680	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.442	1.000	8.66	8.66	[0.2 - 2]
assetTurnoverTTM	0.978	0.800	6.82	5.45	[0.5 - 2]
Total Score				11.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	6.61	1.000	9.43	0	[1 - 100]
returnOnEquityTTM	0.112	2.50	9.91	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.411	2.00	9.86	10.00	[0 - 30]
dividendYielPercentageTTM	4.47	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.897	2.00	9.70	10.00	[0 - 30]
payoutRatioTTM	0.354	1.500	6.46	-6.46	[0 - 1]
pegRatioTTM	0.0226	1.500	-3.18	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0741	1.000	-0.646	0	[0.1 - 0.5]
Total Score				5.37

Shandong Xinhua

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.